Revisiting non-HACEK gram-negative endocarditis: Emerging clinical and microbiological trends from a prospective cohort Durga Shankar Meena, Deepak Kumar, Bhuvanesh Kumar, Gopal Krishana Bohra, Naresh Midha, Rahul Choudhary, Surender Deora, Vibhor Tak, Alok Kumar Sharma, Mahesh Devnani Indian Heart Journal, 2026 BACKGROUND: Non-HACEK gram-negative pathogens are an emerging cause of infective endocarditis (IE) with limited data from lower-middle-income countries. This study aimed to evaluate the clinical characteristics, treatment, and outcomes of non-HACEK gram-negative IE in an Indian cohort. METHODS: This prospective observational study was conducted in a tertiary care center in western India. Clinical presentation, microbiology, echocardiographic findings, and treatment outcomes of non-HACEK gram-negative IE were analyzed and compared with patients who had IE due to other etiology. RESULTS: Among 121 patients with IE, 30 cases (24.8%) were due to non-HACEK gram-negative pathogens (median age: 48 years; 73.3% male). In this group, predisposing cardiac conditions were present in 56%, including prosthetic valves/devices in 26.6%. Pseudomonas aeruginosa was the most common etiology (n = 14, 46.6%), followed by E. coli (n = 6, 20%). The median vegetation size was 12 mm. Common complications included heart failure (56.7%), peripheral septic emboli (40%), and stroke (33.3%). Surgical intervention was performed in 23.3% of cases. The 60-day and 1-year mortality rates were 36% and 43.3%, respectively; relapse occurred in 11.8% of 1-year survivors. Compared to other etiology (n = 91), non-HACEK gram-negative IE had a significantly higher Charlson Comorbidity Index (2 vs 1, p = 0.035), persistent bacteremia (30% vs 12%, p = 0.02), and 60-day mortality (36.6% vs 17.6%, p = 0.032). CONCLUSIONS: Non-HACEK gram-negative IE predominantly caused by Pseudomonas aeruginosa, is increasingly recognized. Compared to other etiology, Non-HACEK gram-negative IE was linked to higher comorbidity scores, frequent persistent bacteremia, and greater early mortality, highlighting its aggressive clinical course.
Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial Dorairaj Prabhakaran, Ambuj Roy, Ambalam M. Chandrasekaran, Dimple Kondal, Somnath Mukherjee, Gaia Kiru, Kavita Singh, Hyndavi Salwa, Edmin Christa Sobitharaj, Ameeka Shereen Lobo, Gayatri Mahajan, Bishav Mohan, Aman Khanna, Amit Malviya, Satish G. Patil, Vinod K. Abichandani, Bhupinder Singh, Bal Kishan Gupta, Balsubramaiam Yellapantula, Shailendra Dandge, Shantanu Sengupta, Sunil Kumar, Neil Bardoloi, Nagendra Boopathy Senguttuvan, Rakesh Kumar Sahay, Suvarna Patil, Surender Deora, Rajpurohit Prahalad, Vijaya Parthasaradhi Sarvepalli, Justin Paul Gnanaraj, Mallika Khanna, Animesh Mishra, Kiran Aithal, Vipul Chavda, Victoria R. Cornelius, , Kyrshanglang G. Lynrah, Gurpreet Singh Wander, Gautam Singal, Akash Batta, Ankush Mittal, Suraj Kumar, Deepak Chaudhary, Maninder Kansal, B. K. Gupta, Jigyasa Gupta, Balsubramaniam Yellapantula, Ankita Kapse, D. Shailendra, M. Sneha Manju, M. Suchitra Uikey, Aniket Wazade, Prathibha Pereira, K. M. Srinath, K. C. Shashidhara, Vinay Kumar, Ajay Hanumamthu, K. S. Poornima, Dhanjit Nath, Amitava Misra, Mohini Singh, S. Lekshmi, Said Jabir, Sachin Surnar, Pranav Shamraj, Jyoti L. Iyer, Deepti Mathur, M. B. Shalini, S. V. Partha Saradhi, Rajendran Velayudham, Sudha Kulur Mukhyaprana, Hariharan Chellapandy, Vivek Jaganathan, Ramadevi Kanakasabapathi, E. Theranirajan, Debomallya Bhuyan, Barnali Bhuyan, Shoubhik Bhattacharjee, Sindhuja Kunapareddy, Ambuj Roy, Sandeep Singh, Sayavir Yadav, Kamar Ali, P. B. Jayagopal, Vinit Kr Shah, L. Sreenivasa Murthy, G. Pramod Bagali, P. V. Raghav Sarma, Chinta Srinivasarao, Sharan Badiger, Avinash V. Jugati, Saptarshi Bhattacharya, O. R. Kumaran, Anitha Kolukula, Harika Menti, H. C. Kalita, Hemant Thacker, Abhishek Subhas, Sudhir Varma, Harpreet Kalra, Sanchit Sood, Navjot Kaur, Prabh Simranpal, Taniya Aggarwal, Jabir Abdullakutty, Prashant Kr Sahoo, Sharmila Moharana, Yusuf A. Kumble, P. N. Sandhya Rani, Neil R. Poulter Nature Medicine, 2025 Evidence is lacking for guiding optimal combination hypertension therapy in South Asian patients. Here we investigated the blood pressure (BP)-lowering efficacy and safety of three commonly recommended antihypertensive dual combinations in a multicenter, single-blinded trial conducted in India. We randomized Indians aged 30–79 years (mean age, 52 years) with mean sitting systolic blood pressure (SBP) of 150–179 mmHg on no treatment or an SBP of 140–159 mmHg on monotherapy 1:1:1 to a single-pill combination of amlodipine–perindopril, perindopril–indapamide or amlodipine–indapamide. The primary outcome was the mean change in 24-hour ambulatory SBP at 6 months. Of the 1,981 participants (42% females) enrolled in the trial, 1,637 completed a 24-hour ambulatory BP measurement. All three drug combinations produced similar large reductions in the primary outcome, namely ambulatory (~14/8 mmHg) and office (~30/14 mmHg) BPs after 6 months, such that hypertension control rates (sitting BP < 140/90 mmHg) were achieved in approximately 70% of participants in all three groups. Furthermore, no significant differences in secondary outcomes, such as mean day and night ambulatory and office BPs and hypertension control rates, were observed among the study groups. Thus, in Indian patients, amlodipine–perindopril, perindopril–indapamide and amlodipine–indapamide were all equally well tolerated and equally highly effective in reducing 24-hour ambulatory and office BPs (ClinicalTrials.gov registration: NCT05683301 ). To address an evidence gap for the efficacy of hypertension therapy using dual drug combinations in patients of South Asian origin, a randomized clinical trial conducted in India found that three types of dual drug combinations, each administered in a single pill, had similarly large effects on reducing blood pressure.
Efficacy & safety of stem cell therapy for treatment of acute myocardial infarction: A systematic review & meta-analysis Pravesh Aggarwal, Ranu R. Oza, Hitendrapal Solanki, Jaykaran Charan, Rimple Jeet Kaur, Surender Deora, Lokesh Saini, Deepak Kumar, Rahul Choudhary, Pankaj Bhardwaj, Tanuj Kanchan, Siddhartha Dutta Indian Journal of Medical Research, 2025 Background & Objectives Stem cell based therapeutic treatments have been used as a management strategy for acute myocardial infarction (AMI), a common primary factor causing death globally. We aimed to undertake a meta-analysis of studies including randomised controlled trials (RCTs) examining different stem cell preparations in AMI, as a definitive answer from this therapeutic approach is yet to emerge. Methods Following PROSPERO registration (CRD42024628552), a systematic search was conducted through PubMed database, Embase, Cochrane, and Web of Science. Data was analysed using RevMan 5.4.1. Primary outcomes included all-cause mortality, recurrent myocardial infarction (Re-MI), severe adverse events (SAEs), hospitalisation for heart failure, cancer incidence, and left ventricular ejection fraction (LVEF). A fixed-effect model was used to assess six outcomes: all-cause mortality, Re-MI, SAEs, heart failure hospitalisation, cancer incidence, and stroke. A model based on random effects depending on heterogeneity was used to assess LVEF. Results From 9,516 records, 48 studies were included for analysis based on available endpoints. No notable changes in all-cause mortality were observed between patients receiving stem cell therapy and those in the control group, according to the meta-analysis. [Risk Ratio (RR) 0.73], SAEs (RR 0.93), Re-MI (RR 0.67), HF-related hospitalisation (RR 0.79), cancer (RR 0.82), or stroke (RR 0.81). Echocardiographic LVEF improved significantly at study end [Mean difference (MD) 2.53%] and difference from baseline (MD 3.89%), with high heterogeneity (I2 - 76%). MRI-assessed LVEF showed no significant change at study end (MD 0.83%) but improved from baseline (MD 1.37%). Heterogeneity was low except for LVEF, with serious bias risk for most outcomes and very serious for Re-MI and SAEs, though their objective nature limits bias Interpretation & conclusions Analysis done found no significant benefit of stem cell-based therapies on clinical endpoints in AMI patients.
Prevalence of periodontitis in chronic heart failure patients and its relationship with NT-ProBNP: A cross-sectional study Sonika Sharma, Deepti Mathur, Sourabh Goswami, Manoj Kumar Gupta, Pankaj Bhardwaj, Pravin Kumar, Surender Deora Indian Heart Journal, 2025 BACKGROUND: Periodontal disease has been associated with chronic heart failure (CHF) and may be an indicator of high risk of adverse cardiovascular outcomes. To date, only few studies have been done and none from India regarding the association of periodontal disease in heart failure patients. So, this study was done to assess the prevalence of periodontitis in CHF patients and its correlation with N-terminal pro brain natriuretic peptide (NT- ProBNP). MATERIALS AND METHOD: In this study, 154 patients with stable CHF with left ventricular ejection fraction of less than 40 % were enrolled. All subjects underwent cardiologic and dental evaluations. NT pro-BNP level was measured in all patients. The periodontal screening index was used to quantify the degree of periodontal disease. RESULTS: Gingivitis, moderate periodontitis, and severe periodontitis were present in 48 (31.2 %), 82 (53.2 %), and 24 (15.5 %) patients, respectively. In individuals under the age of 75 years, the study found a significant association between moderate and severe periodontitis and elevated NT-proBNP levels (p < 0.05). The comparison between gingivitis and moderate/severe periodontitis was statistically significant in post hoc analysis. CONCLUSION: CHF patients exhibit a high prevalence of moderate and severe periodontitis. This study highlights a significant association between periodontitis severity and elevated NT-proBNP in CHF patients, underscoring a potential cardiac impact. Further research is warranted to deepen our understanding of this relationship.
Comparative Efficacy of Mechanical Versus Manual Compression Techniques on Radial Artery Hemostasis Following Transradial Coronary Angiography: A Meta-Analysis Hritvik Jain, Maryam Shahzad, Nandan Patel, Jyoti Jain, Ramez M. Odat, Raheel Ahmed, Surender Deora Cardiology in Review, 2025 Mechanical compression for hemostasis posttransradial coronary angiography (CAG) or intervention is hypothesized to be more effective than manual compression owing to a more stable and continuous pressure. However, the current evidence comparing these 2 compression techniques is limited. A comprehensive search of the 3 major electronic databases—PubMed, Google Scholar, and Cochrane Library—was performed from inception to October 24, 2024, to identify relevant studies. Standardized mean difference and risk ratios (RR) with 95% confidence intervals (CIs) were pooled using the Mantel-Haenszel random effects model to calculate effect estimates. Statistical significance was set at P < 0.05. Four studies with 1235 patients undergoing transradial CAG were included [mechanical (n = 450) and manual (n = 785)]. On pooled analysis, the mechanical compression method demonstrated a significantly longer mean time to achieve hemostasis (standardized mean difference: 3.21; 95% CI: 1.71, 4.71; P < 0.0001) than the manual compression method. The risks of radial artery occlusion (RR: 1.05; 95% CI: 0.50, 2.22; P = 0.89), hematoma formation (RR: 1.86; 95% CI: 0.28, 12.40; P = 0.52), and bleeding during compression (RR: 0.23; 95% CI: 0.00, 24.81; P = 0.54) were comparable. Both types of hemostatic compression, manual and mechanical, are equally effective though mechanical compression takes significantly longer to achieve hemostasis. Further prospective randomized studies are needed to corroborate these findings.
Molecular and Functional Significance of Growth Differentiation Factor-15: A Review on Cardiovascular-Kidney-Metabolic Biomarker Krishna Tiwari, Aswini Saravanan, Abhishek Anil, Vikas Kumar Tiwari, Muhammad Aaqib Shamim, Surjit Singh, Pradeep Dwivedi, Surender Deora, Shoban Babu Varthya Current Cardiology Reviews, 2025 Cardiovascular-kidney-metabolic (CKM) syndrome is the association between obesity, diabetes, CKD (chronic kidney disease), and cardiovascular disease. GDF-15 mainly acts through the GFRAL (Glial cell line-derived neurotrophic factor Family Receptor Alpha-Like) receptor. GDF-15 and GDFRAL complex act mainly through RET co-receptors, further activating Ras and phosphatidylinositol-3-kinase (PI3K)/Akt pathways through downstream signaling. GDF-15 decreases cardiac dysfunction and hypertrophy by inducing HIF-α (hypoxia-inducible factor-1α). It causes increased fractional shortening and a significant decrease in ventricular dilation through the induction of the SMAD 2/3. GDF-15 prevents hyperglycemia-induced apoptosis in diabetes mellitus. GDF-15 causes anorexia by influencing the central systems regulating metabolism and appetite. Therefore, targeting GDF-15 can be useful for the treatment of anorexia caused by cancer as well as the prevention of resulting weight loss. GDF-15 has an important role in predicting mortality in acute kidney injury. Its high levels are related to eGFR decline and also have a prognostic role in CKD patients. Growth differentiation factor-15 (GDF-15) is a vital biomarker for diagnosis, treatment, and prognosis of CKM syndrome. Elevated GDF-15 levels can be utilised as a biomarker to determine the suitable metformin dosage. In light chain amyloidosis, a raised level of GDF-15 predicts early death in heart failure and renal disease patients. In vivo, studies using GDF-15 analogs and antibodies against GFRAL to affect metabolic parameters and ventricular dilatation have shown potential for GDF-15-based therapeutic interventions. This review aims to study the role of GDF-15 in CKM syndrome and establish it as a CKM biomarker.
Marked Global Differences in Mortality in Male Patients with COVID-19: An Analysis of the CARDIO COVID 19–20 and WHF COVID-19 CVD Studies Juan Esteban Gómez-Mesa, Juan Pablo Arango-Ibanez, Pablo Perel, Dorairaj Prabhakaran, Hoover O. León-Giraldo, Alejandro Toro-Pedroza, Ricardo Enrique Larrea Gómez, César J. Herrera, Julián Lugo-Peña, Liliana Patricia Cárdenas Alaz, Victor Rossel, Daniel Sierra-Lara, Jessica Mercedes, Clara Inés Saldarriaga-Giraldo, María Juliana Rodríguez-González, Armando Alvarado, Juan Carlos Ortega, Miguel Quintana Da Silva, Kavita Singh, Karen Sliwa Global Heart, 2025 Background: COVID-19 has led to nearly seven million deaths and male sex has been reported as one of the main risk factors for mortality. Few studies have analyzed cohorts of male patients, especially in underrepresented regions in the medical literature, such as low and middle-income nations. To address this gap, we conducted large-scale, male-specific, multinational analyses, to improve understanding of factors associated with mortality in this high-risk population and global variations. Methods: This is a prospective, multicenter study that includes data from the CARDIO COVID-19–20 registry and the WHF COVID-19 CVD study. A multiple Poisson regression model was performed to evaluate differences in factors associated with in-hospital mortality among male COVID-19 patients across different regions. Results: We analyzed 4,899 hospitalized male COVID-19 patients from 32 countries: Africa (11.2%), the Americas (44.7%), Asia (33.8%), and Europe (10.2%). Median age was 59 years (IQR: 47–69), with 50.5% aged 40–64. ICU admission was 42.4%, and mortality was 19.2%, with marked regional differences (ranging from 6% in Europe to 26.9% in the Americas). Poisson regression showed age >80 years (aRR = 4.21) and IMV (aRR = 3.80) as the strongest factors associated with mortality. Other factors included diabetes, chronic kidney disease, myocarditis, and decompensated heart failure. Mortality risk was higher in Africa (aRR = 3.86), Asia (aRR = 2.72), and the Americas (aRR = 2.23) compared to Europe (p < 0.001). Anticoagulation/Antiplatelet therapy showed a potential correlation with survival. Conclusion: This study reflects the complexity of factors influencing COVID-19 mortality among male patients hospitalized with COVID-19, emphasizing global variability. The substantial differences in mortality noted across countries are likely due to differences in disease severity, comorbidities, clinical care, and health system factors. Age remains a primary risk factor, with older populations particularly vulnerable. Our findings underscore the need for targeted and tailored regional approaches to manage male COVID-19 patients.
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study Dorairaj Prabhakaran, Kavita Singh, Dimple Kondal, Lana Raspail, Bishav Mohan, Toru Kato, Nizal Sarrafzadegan, Shamim Hayder Talukder, Shahin Akter, Mohammad Robed Amin, Fastone Goma, Juan Gomez-Mesa, Ntobeko Ntusi, Francisca Inofomoh, Surender Deora, Evgenii Philippov, Alla Svarovskaya, Alexandra Konradi, Aurelio Puentes, Okechukwu S. Ogah, Bojan Stanetic, Aurora Issa, Friedrich Thienemann, Dafsah Juzar, Ezequiel Zaidel, Sana Sheikh, Dike Ojji, Carolyn S. P. Lam, Junbo Ge, Amitava Banerjee, L. Kristin Newby, Antonio Luiz P. Ribeiro, Samuel Gidding, Fausto Pinto, Pablo Perel, Karen Sliwa Global Heart, 2022
Percutaneous transvenous mitral commissurotomy - A modified over-the-wire technique for difficult left ventricle entry Journal of Invasive Cardiology, 2013
Effect of Nurse-Led mHealth Educational Intervention on Self-Care Behavior, Clinical Outcomes, and Quality of Life Among Heart Failure Patients: A Systematic Review of … N Kalal, SK Sharma, A Kumar, S Deora Advances in Mind-body Medicine, ADV1444-ADV1444 , 2026 2026
Nurse-Led mHealth: Redefining Self-Care in Heart Failure Through a Mind–Body Lens S Deora Heart and Mind , 2026 2026
Revisiting Non-HACEK Gram-Negative Endocarditis: Emerging Clinical and Microbiological Trends from a Prospective Cohort DS Meena, D Kumar, B Kumar, GK Bohra, N Midha, R Choudhary, ... Indian Heart Journal , 2026 2026
A CNN-based classifier for detecting rhythm disorders, premature contractions, and conduction abnormalities from ECG S Gaurhar, AK Tiwari, S Deora Biomedical Signal Processing and Control 113, 108834 , 2026 2026
Coronary Stent Infection Reimagined: A Non-surgical Victory Against a Rare Cardiac Complication GK Medarametla, R Choudhary, S Deora, N Bordiya, A Yadav, S DEORA Cureus 18 (2) , 2026 2026
Isolated Double-Chambered Right Ventricle in an Adult Patient: Diagnosis to Management GK Medarametla, S Deora, A Kaushik, R Choudhary, M Katti, S DEORA Cureus 17 (12) , 2025 2025
Neutrophil-To-Lymphocyte Ratio (NLR) as a Predictor of Coronary Artery Disease Severity in Chronic Stable Angina Patients K Gaur, S Deora, A Yadav Indian Heart Journal 77, S46 , 2025 2025
Role of Remote Dielectric Sensing in Optimizing Heart Failure Care: An Indian Pilot Study G Medarametla, S Deora, A Kaushik, R Choudhary, N Bordiya, K Gaur, ... Indian Heart Journal 77, S75 , 2025 2025
Effect of SGLT2 inhibitor therapy on left ventricular longitudinal and circumferential strain in patients with type 2 diabetes mellitus and normal left ventricular ejection … A Kaushik, R Gudhage, S Deora, S Patel, R Choudhary European Heart Journal 46 (Supplement_1) , 2025 2025
Clinical outcomes with early discharge versus late discharge in transcatheter aortic valve replacement: A meta-analysis H Jain, T Warsi, S Passey, J Oza, H Naveed, K Soni, R Kelkar, N Barve, ... European Heart Journal 46 (Supplement_1), ehaf784. 2414 , 2025 2025
Assessment of relationship between ventricular repolarization variables and cardiac diastolic function and global longitudinal strain in newly diagnosed hypertensive patients A Kaushik, GK Medarametla, S Deora, R Choudhary, S Patel European Heart Journal 46 (Supplement_1), ehaf784. 3416 , 2025 2025
RWD277 COST-UTILITY IN DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN THERAPY IN HEART FAILURE WITH REDUCED EJECTION FRACTION [DESTINY-HF]: A PRAGMATIC RANDOMIZED CONTROLLED TRIAL … K Tiwari, P Dwivedi, MA Shamim, S Singh, S Ambwani, S Deora, ... Value in Health Regional Issues 49 , 2025 2025
Predictive value of lymphocyte based indices to determine Major adverse cardiovascular events in acute coronary syndrome undergoing percutaneous coronary intervention V Mohanty, S Deora, A Kaushik, R Choudhary, D Yadav, K Singh Indian Journal of Clinical Biochemistry 40 (4), 619-627 , 2025 2025 Citations: 3
Comparison of dual therapies for hypertension treatment in India: a randomized clinical trial D Prabhakaran, A Roy, AM Chandrasekaran, D Kondal, S Mukherjee, ... Nature Medicine 31 (9), 3169-3175 , 2025 2025 Citations: 5
Efficacy & safety of stem cell therapy for treatment of acute myocardial infarction: A systematic review & meta-analysis P Aggarwal, RR Oza, H Solanki, J Charan, RJ Kaur, S Deora, L Saini, ... The Indian Journal of Medical Research 161 (6), 647 , 2025 2025 Citations: 2
Efficacy and safety of dapagliflozin versus sacubitril-valsartan therapy in heart failure with reduced ejection fraction [DESTINY-HF] K Tiwari, MA Shamim, S Deora, A Kaushik, R Choudhary, ... EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 81 (1), S48-S48 , 2025 2025
Health status in a pragmatic randomized controlled trial of dapagliflozin versus sacubitril-valsartan therapy in heart failure with reduced ejection fraction S Singh, K Tiwari, S Deora, A Kaushik, R Choudhary, P Dwivedi, ... EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 81 (1), S39-S39 , 2025 2025
F-118| Comparative Efficacy of Mechanical Versus Manual Compression Techniques on Radial Artery Hemostasis Following Transradial Coronary Angiography: A Meta-Analysis H Jain, M Shahzad, R Patel, N Patel, D Singh, M Mal, J Jain, F Ahmed, ... Journal of the Society for Cardiovascular Angiography & Interventions 4 (5) , 2025 2025
Molecular and Functional Significance of Growth Differentiation Factor-15: A Review on Cardiovascular-Kidney-Metabolic Biomarker K Tiwari, A Saravanan, A Anil, VK Tiwari, MA Shamim, S Singh, P Dwivedi, ... Current Cardiology Reviews 21 (3), E1573403X332671 , 2025 2025 Citations: 6
RANDOMIZED CONTROL STUDY OF PRE-EXTUBATION CARDIOPULMONARY SONOGRAPHY RESULTING IN SHORTER ICU STAY POST EXTUBATION P Parida, N Dutt, N Chauhan, K Kalra, Ramniwas, M Garg, P Bhatia, ... INTERNAL MEDICINE JOURNAL 55, 111-111 , 2025 2025
MOST CITED SCHOLAR PUBLICATIONS
Demographic and angiographic profile in premature cases of acute coronary syndrome: analysis of 820 young patients from South India S Deora, T Kumar, R Ramalingam, CN Manjunath Cardiovascular diagnosis and therapy 6 (3), 193 , 2016 2016 Citations: 111
Prolonged Tpeak-end and Tpeak-end/QT ratio as predictors of malignant ventricular arrhythmias in the acute phase of ST-segment elevation myocardial infarction: a prospective … J Shenthar, S Deora, M Rai, CN Manjunath Heart rhythm 12 (3), 484-489 , 2015 2015 Citations: 68
Cardiovascular risk factors and clinical outcomes among patients hospitalized with COVID-19: findings from the world heart Federation COVID-19 study D Prabhakaran, K Singh, D Kondal, L Raspail, B Mohan, T Kato, ... Global Heart 17 (1), 40 , 2022 2022 Citations: 43
Working through challenges of subclavian, innominate, and aortic arch regions during transradial approach T Patel, S Shah, S Pancholy, S Deora, K Prajapati, J Coppola, IC Gilchrist Catheterization and Cardiovascular Interventions 84 (2), 224-235 , 2014 2014 Citations: 38
Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study MM Pinto-Filho, GM Paixão, PR Gomes, CPM Soares, K Singh, VA Rossi, ... Heart 109 (9), 668-673 , 2023 2023 Citations: 26
Air pollution and its impact on cardiovascular health–It's time to act fast! R Yadav, S Deora, G Yadav Indian Heart Journal 73 (1), 1-6 , 2021 2021 Citations: 26
Utility of transradial approach for peripheral vascular interventions. T Patel, S Shah, S Pancholy, S Deora, K Sanghvi, R Gulati, J Coppola The Journal of Invasive Cardiology 27 (6), 277-282 , 2015 2015 Citations: 24
Working through complexities of radial and brachial vasculature during transradial approach T Patel, S Shah, S Pancholy, R Radadiya, S Deora, C Vyas, M Hamon, ... Catheterization and Cardiovascular Interventions 83 (7), 1074-1088 , 2014 2014 Citations: 23
Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA A Kaushik, S Deora, R Choudhary New England Journal of Medicine 383 (17), 1692-1693 , 2020 2020 Citations: 19
Assessment and comparison of distal radial artery diameter in anatomical snuff box with conventional radial artery before coronary catheterization S Deora, SK Sharma, R Choudhary, A Kaushik, PK Garg, PS Khera, ... Indian Heart Journal 74 (4), 322-326 , 2022 2022 Citations: 18
The development and randomised feasibility trial of a Nurse-led lifestyle modification follow-up programme among post-myocardial infarction patients S Yadav, N Kalal, SK Sharma, S Deora Journal of Research in Nursing 28 (3), 230-246 , 2023 2023 Citations: 15
Balloon-assisted tracking of guide catheter dealing with radial artery perforation and subclavian loop during percutaneous coronary intervention by transradial approach S Deora, S Shah, T Patel International Journal of Cardiology 167 (6), e161-e162 , 2013 2013 Citations: 15
Epidemiology, etiology and clinical associations of congenital heart disease identified during congenital rubella syndrome surveillance P Priyanka, V Vyas, S Deora, VL Nag, K Singh Journal of Tropical Pediatrics 68 (6), fmac089 , 2022 2022 Citations: 13
Percutaneous transvenous mitral commissurotomy: a modified over-the-wire technique for difficult left ventricle entry. S Deora, C Vyas, S Shah The Journal of Invasive Cardiology 25 (9), 471-473 , 2013 2013 Citations: 13
Percutaneous balloon pulmonary valvuloplasty: a modified over-the-wire Inoue balloon technique for difficult right ventricular anatomy S Deora, C Vyas, S Shah, T Patel indian heart journal 66 (2), 211-213 , 2014 2014 Citations: 11
Assessment of preoperative and postoperative cardiac function in children with adenotonsillar hypertrophy: a prospective cohort study VV Sameema, K Soni, S Deora, JB Sharma, B Choudhury, D Kaushal, ... European Archives of Oto-Rhino-Laryngology 279 (6), 3013-3019 , 2022 2022 Citations: 10
Balloon-assisted tracking in dealing with radial artery loop by transradial approach: a technical report. S Deora, S Shah, T Patel The Journal of Invasive Cardiology 26 (5), E61-2 , 2014 2014 Citations: 10
Hydroxychloroquine as therapeutic option in COVID-19: analysis of suspected cardiovascular adverse drug events reported in the vigibase S Dutta, R Kaur, P Bhardwaj, S Deora, K Singh, S Ambwani, J Charan, ... Bangladesh Journal of Medical Science 20 (4), 897-910 , 2021 2021 Citations: 9
Awareness, medication adherence, and diet pattern among hypertensive patients attending teaching institution in western Rajasthan, India D Mathur, S Deora, A Kaushik, P Bhardwaj, K Singh Journal of Family Medicine and Primary Care 9 (5), 2342-2349 , 2020 2020 Citations: 9
Saphenous vein graft perforation during percutaneous coronary intervention-a nightmare to be avoided S Deora, SC Shah, TM Patel Heart Views 16 (1), 34-36 , 2015 2015 Citations: 9